Muscular dystrophies: diagnostic approaches in Hungary

被引:0
|
作者
Piko, H. [1 ]
Vancso, V. [1 ]
Nagy, B. [2 ]
Balog, J. [1 ]
Nagymihaly, M. [1 ]
Herczegfalvi, A. [3 ]
Timar, L. [4 ]
Ban, Z. [2 ]
Karcagi, V. [1 ]
机构
[1] Natl Inst Environm Hlth, Dept Mol Genet & Diagnost, H-1096 Budapest, Hungary
[2] Semmelweis Univ, Clin Obstet & Gynaecol, Genet Lab, H-1085 Budapest, Hungary
[3] Bethesda Childrens Hosp, Dept Neurol, Budapest, Hungary
[4] Natl Inst Child Hlth, Dept Genet Counselling, Budapest, Hungary
关键词
Duchenne/Becker muscular dystrophy; facioscapulohumeral muscular dystrophy; MLPA;
D O I
10.1556/APhysiol.95.2008.4.7
中图分类号
学科分类号
摘要
Muscular dystrophies are a genetically heterogeneous group of degenerative muscle disorders. This article focuses on two severe forms of muscular dystrophies and provides genetic data for a large cohort of Hungarian patients diagnosed within the last few years by the authors. The Duchenne/Becker muscular dystrophy (DMD/BMD) is caused by mutations in the dystrophin gene, which is located on chromosome Xp21. The genetic analysis of dystrophin is usually performed by multiplex polymerase chain reaction (PCR), which detects approximately 95% of all deletions but does not distinguish between one and two copies of the exons investigated. The present work, therefore, concentrates on the improvement of the diagnostic panel for the analysis of DMD/BMD in Hungary. Radioactively labelled cDNA probes, encompassing the whole dystrophin gene detect all the deletions and the analysis is quantitative. In addition, the new multiple ligation-dependent probe amplification (MLPA) technique was recently introduced that enabled more reliable and faster quantitative detection of the entire dystrophin gene. The genomic basis of facioscapulohumeral muscular dystrophy (FSHD) is associated with contraction of the D4Z4 repeat region in the subtelomere of chromosome 4q. In case of FSHD, molecular genetic criteria still have to be improved because of the complexity of the disorder.
引用
收藏
页码:405 / 418
页数:14
相关论文
共 50 条
  • [1] Therapeutic Approaches to Muscular Dystrophies
    Goyenvalle, Aurelie
    [J]. CURRENT GENE THERAPY, 2012, 12 (03) : 137 - 138
  • [2] Experimental and therapeutic approaches to muscular dystrophies
    Skuk, D
    Vilquin, JT
    Tremblay, JP
    [J]. CURRENT OPINION IN NEUROLOGY, 2002, 15 (05) : 563 - 569
  • [3] Novel approaches to treat muscular dystrophies
    Walter, MC
    Lochmüller, H
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (04) : 695 - 707
  • [4] Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies
    Rawls, Alan
    Diviak, Bridget K.
    Smith, Cameron I.
    Severson, Grant W.
    Acosta, Sofia A.
    Wilson-Rawls, Jeanne
    [J]. BIOMOLECULES, 2023, 13 (10)
  • [5] Closing the diagnostic gap on muscular dystrophies
    Zimmer, F.
    Pluta, N.
    Wolf, B.
    Atlan, D.
    Zaum, A.
    Rost, S.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 952 - 953
  • [6] Diagnostic approach to the congenital muscular dystrophies
    Boennemann, Carsten G.
    Wang, Ching H.
    Quijano-Roy, Susana
    Deconinck, Nicolas
    Bertini, Enrico
    Ferreiro, Ana
    Muntoni, Francesco
    Sewry, Caroline
    Beroud, Christophe
    Mathews, Katherine D.
    Moore, Steven A.
    Bellini, Jonathan
    Rutkowski, Anne
    North, Kathryn N.
    [J]. NEUROMUSCULAR DISORDERS, 2014, 24 (04) : 289 - 311
  • [7] Two approaches to therapy for muscular dystrophies in Russia.
    Shishkin, SS
    Shakhovskaya, NI
    Skosobzeva, LF
    Artemieva, SB
    Krakhmaleva, IN
    Khodunova, AA
    Gerasimova, NL
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 261 - 261
  • [8] Diagnostic strategy for limb-girdle muscular dystrophies
    Eyrnard, B.
    Levy, N.
    [J]. REVUE NEUROLOGIQUE, 2012, 168 (12) : 919 - 926
  • [9] The limb-girdle muscular dystrophies - Diagnostic strategies
    Bushby, Kate
    Norwood, Fiona
    Straub, Volker
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (02): : 238 - 242
  • [10] Combined approaches to diagnosis of congenital muscular dystrophies with α-dystroglycan hypoglycosylation
    Bouchet, C.
    Manya, H.
    Yanagisawa, A.
    Maugenre, S.
    Quijano-Roy, S.
    Estournet, B.
    Merlini, L.
    Topaloglu, H.
    Romero, N. B.
    Leturcq, F.
    Seta, N.
    Endo, T.
    Guicheney, P.
    [J]. NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 662 - 662